Bliss GVS Pharma (BLISSGVS) | Stock Overview & Key Data

Bliss GVS Pharma Ltd. | Small-cap | Healthcare

₹157.68

5.96%

| Bliss GVS Pharma Stock Comparison:

No comparison data available

Chart Range Statistics Financials Dividends Returns Ownership Calculator FAQ

Bliss GVS Pharma Performance Comparison

Loading chart data...

Bliss GVS Pharma

NIFTY 50

View Full Price History

Stock Range

Today's Range

Low: ₹148.32 High: ₹159.25

on June 27, 2025

52 Week Range

Low: ₹101.01 High: ₹185.50

on June 28, 2024

on January 3, 2025

All-Time High: ₹221.00 on December 28, 2020

Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights

Key Statistics

Market Cap i INR15.7B

EPS i 7.95

P/E Ratio (TTM) i 18.68

Forward P/E i N/A

P/B Ratio i 1.49

PEG Ratio i 1.71

Div. Yield i 0.36%

ROE i 8.62%

Beta i 0.969

Debt to Equity i 8.07

Financial Highlights

Profitability

Gross Margin i 49.78%

Operating Margin i 6.59%

Profit Margin i 10.41%

Returns and Earnings

Return on Assets (TTM) i 4.84%

Return on Equity (TTM) i 8.62%

EBITDA i INR1.6B

Net Income (TTM) i INR843.0M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Dividend Information

Last 12-Month Dividend i ₹0.50

Current Dividend Yield i 0.36%

3-Year Average Dividend Yield i 0.56%

3-Year Average Annual Dividend i ₹0.50

3-Year Total Dividends i ₹1.50

Ex-Dividend Date i July 18, 2024

Peer Performance Comparison

No peer performance data available for this stock.

Ownership & Short Interest

Insider Ownership i 61.32%

Institutional Ownership i 7.23%

Shares Short i N/A

Short Ratio i N/A

Short % of Shares Outstanding i N/A

Average 10-Day Volume i 1M

Average 90-Day Volume i 728K

Bliss GVS Pharma Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Bliss GVS Pharma would have performed over time.

Investment Amount

INR

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is BLISSGVS's 52-week high and low?

In the last 52 weeks, Bliss GVS Pharma reached a high of ₹185.50 (on January 3, 2025) and a low of ₹101.01 (on June 28, 2024).

What is the market cap and P/E ratio for BLISSGVS?

Curious about Bliss GVS Pharma's size and valuation? Its market capitalization stands at 15.66B. When it comes to valuation, the P/E ratio (trailing twelve months) is 18.68, and the forward P/E (looking ahead) is N/A.

Does BLISSGVS pay dividends? If so, what's the yield?

Yes, Bliss GVS Pharma is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.36%, and the company has paid an average of ₹0.50 per share annually over the past 3 years.

Who are Bliss GVS Pharma's main competitors or similar companies to consider before investing?

When looking at Bliss GVS Pharma, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

No specific competitor data is currently available for comparison in this section.

What are the key financial health indicators for Bliss GVS Pharma Ltd.? (e.g., ROE, Debt/Equity)

To get a sense of Bliss GVS Pharma's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 8.62%, the Debt to Equity ratio from the most recent quarter is 8.07, and its Gross Profit Margin stands at 49.78%.

What is the recent revenue and earnings growth for BLISSGVS?

Looking at Bliss GVS Pharma's growth, its revenue over the trailing twelve months (TTM) was INR8B. Compared to the same quarter last year (YoY), quarterly revenue grew by -0.10%, and quarterly earnings saw a YoY growth of 2.16%.

How much of BLISSGVS stock is held by insiders and institutions?

Wondering who owns Bliss GVS Pharma stock? Company insiders (like executives and directors) hold about 61.32% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 7.23%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.